FOLH1 and prostate carcinoma: Most of the available data on and experiences of PET imaging in prostate carcinomas targeting PSMA are with 68Gallium (68Ga)-labeled urea-based small molecules such as PSMA-HBED-CC (or PSMA-11) and PSMA-617, of which the latter has been tagged with 177Lu/225Ac for therapeutic applications.